Health-related quality of life in women with breast cancer: a review of measures

Salas, Maribel; Mordin, Margaret; Islam, Zahidul; Tu, Nora; Hackshaw, Michelle D.

doi:10.1186/s12885-021-09157-w

Cited by 22 publications

(18 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The Quality of Life (QoL) is an individual's perspective on life based on his or her current circumstances (17,18). Aside from this subjective aspect, QoL instruments are highly valid, reliable, and responsive for measuring important clinical changes and comparing different types and levels of diseases, treatments, or interventions in different situations at a specific time (19,20). A previous study indicated the evaluating adjuvant therapy treatments in 530 cancer patients treated with tamoxifen experience side effects in their emotional, functional, and sexual functions that are manifested in, among others, sleep disturbances, hot flushes, vaginal dryness, and depression (21).…”

mentioning

confidence: 99%

Cross-cultural adaptation and psychometric properties of the Indonesian version for quality of life among breast cancer patients

Solikhah

Perwitasari

Rejeki

2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundBreast cancer is one of the most important health problems worldwide. Quality of life (QoL) is an important indicator to evaluate symptoms in cancer patients, including those with breast cancer. Culturally suitable, valid, reliable, and appropriate instruments to measure the QoL of breast cancer patients are needed, which is still rare in Indonesia. This study aimed to translate the EORTC QLQ-BR45 instrument into Indonesian and evaluate its psychometrics.MethodsA cross-sectional study was performed on 635 patients conveniently selected from the oncology department in referral hospital. The first phase of this study involved translation of the existing EORTC QLQ-BR45 into Indonesian, and in the second phase, we evaluated its psychometric properties. Construct validity was evaluated using confirmatory factor analysis (CFA). Criterion validity was examined according to the association between disease stage and Karnofsky Performance Scale (KPS).ResultsA total of 635 (99.00%) completed the EORTC QLQ-BR45 successfully. The instrument indicated good readability and high content validity. All Cronbach's alpha coefficients were satisfactory (overall value, 0.87). For construct validity, patients with KPS ≥80% did better than those with KPS ≤70% as did two multi-item scales in functional scales (body image and breast satisfaction) and five multi-item scales in symptom scales (systemic therapy side effects, endocrine therapy, and arm, breast, and endocrine sexual symptoms). Body image score of late-stage patients was significantly higher. CFA indicated that the nine-factor structure of the Indonesian EORTC QLQ-BR45 was a good fit for the data.ConclusionThe Indonesian EORTC QLQ-BR45 questionnaire is reliable and valid with good psychometric properties, thus can be used for breast cancer patients in Indonesia.

show abstract

mentioning

confidence: 99%

Cross-cultural adaptation and psychometric properties of the Indonesian version for quality of life among breast cancer patients

Solikhah

Perwitasari

Rejeki

2023

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…[28][29][30][31] Several systematic reviews have been conducted with the goal of identifying which major PROMs questionnaires have been developed specifically for patients with breast cancer facing different stages of disease and treatments. [32][33][34] An interesting example is the work realized by van Egdom et al 32 This review investigated the implementation methods, impact facilitators, and barriers of PROM collection in breast cancer clinical practice.…”

Section: Discussionmentioning

confidence: 99%

Definition of a tool to assess shared decision‐making (SDM) on women with breast cancer: A value‐based approach

Angioletti

Mattia

Carloni

et al. 2022

Health Science Reports

View full text Add to dashboard Cite

Background and Aims: In oncology, there is increasing talk of personalized treatment and shared decision-making (SDM), especially when multiple treatment options are available with different outcomes depending on patient preference. The present study aimed to define the set of main dimensions and relative tools to assess the Value brought to patients from a Breast Cancer's Clinical pathway structured according to a dynamic SDM framework.Methods: Starting from our previous systematic review of the literature, a deep search of the main evidence-based and already validated questionnaires was carried out. In the second phase, to corroborate this grid, a Delphi survey was conducted to assess each questionnaire identified for each dimension, against the following seven value-based criteria: Clinical Benefit, Safety, Care Team Well Being, Patient Reported Outcomes Measures, Green Oncology, Impact on Health Budget, and Genomic Profile.Results: The resulting 7-dimension questionnaire is composed of 72 questions. Of these, some quantitatively and objectively assess the evolution of the patient's disease state, whereas others aim to ask patients about their active involvement in decisions affecting them and to investigate whether they were free to explore their preferences. Furthermore, to frame the analyzed phenomenon at the right time, for each questionnaire section, the specific, evidence-based timing of administration is indicated. Conclusion:The resulting questionnaire is validated in its entirety and it is composed of a set of questions and relative time point for data collections to assess the Value brought to patients undertaking a Breast Cancer's Clinical pathway, structured according to a dynamic SDM framework. It constitutes a quantitative instrument to integrate patient centeredness with a personalized perspective in the care management of women with breast cancer.

show abstract

“…QOL was assessed using the German version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30; version 3.0). This is a widely used questionnaire that has been validated in different patient groups and many languages [ 15 , 35 ]. The EORTC QLQ-C30 comprises 30 items divided among five functional scales (physical, role, cognitive, emotional, and social functioning), nine symptom scales/items (fatigue, nausea/vomiting, pain, dyspnoea, insomnia, appetite loss, constipation, diarrhoea, financial difficulties), and a global health/QOL scale.…”

Section: Methodsmentioning

confidence: 99%

Young Adult German Breast Cancer Patients Participating in a Three-Week Inpatient Mother–Child Rehab Program Have High Needs for Supportive Care

Hammersen

Fischer

Pursche³

et al. 2023

Cancers

View full text Add to dashboard Cite

A known cut-off problem hampers the interpretation of quality of life (QOL) scores. The purpose of this study was to apply a novel approach for the EORTC QLQ-C30 instrument to identify the proportion of breast cancer (BC) patients in need of supportive care. Changes in QOL during the COVID-19 pandemic were evaluated, as well as changes over time (after treatment termination and up to 4 years later). Data were obtained from a cohort study on young adult BC patients with minor children participating in a mother–child rehab program. Cross-sectional QOL data were collected from 2015 to 2021 (baseline). Follow-up data were available for up to 4 years after diagnosis for a subgroup. The baseline cohort included 853 women (mean age 35 years). More than 50% had a need for supportive care. In the subgroup with follow-up, this proportion remained at a high level up to several years after diagnosis. During the COVID-19 pandemic, changes regarding the proportion with this need were not as high as expected—with the exception of changes on the QLQ-C30 scale ‘role functioning’ (+15%). Even several years after diagnosis, every second BC patient with minor children had a need for supportive care, which is much higher than previously found. Healthcare staff should be aware of this potential need and should address this issue.

show abstract

Health-related quality of life in women with breast cancer: a review of measures

Cited by 22 publications

References 38 publications

Cross-cultural adaptation and psychometric properties of the Indonesian version for quality of life among breast cancer patients

Cross-cultural adaptation and psychometric properties of the Indonesian version for quality of life among breast cancer patients

Definition of a tool to assess shared decision‐making (SDM) on women with breast cancer: A value‐based approach

Young Adult German Breast Cancer Patients Participating in a Three-Week Inpatient Mother–Child Rehab Program Have High Needs for Supportive Care

Contact Info

Product

Resources

About